Jessica K. Altman, MD, is a Professor in the Division of Hematology/Oncology at Northwestern University Feinberg School of Medicine. She also serves as Director of the Leukemia Program at Robert H. Lurie Cancer Center of Northwestern University. Dr. Altman received her medical degree from the University of Pittsburgh. She completed her residency in internal medicine at the University of Chicago and fellowship in
hematology and oncology at Northwestern McGaw/Northwestern Memorial Hospital. She is board certified in hematology. Dr. Altman's clinical and research interests include acute and chronic leukemias, anemia, myelodysplastic syndromes, and myeloproliferative diseases. She has published and presented extensively in these disease areas. She is the chair of the clinical trial audit committee of the Robert H. Lurie Comprehensive Cancer Center. She is also a member of the Northwestern Medicine Developmental Therapeutics Program, the Signal Transduction in Cancer Program, and the Hematologic Malignancies Program at the Robert H. Lurie Cancer Center. Her clinical translational research focuses on novel targeted approaches for the treatment of acute leukemia. Dr. Altman is a member of the American Society of Clinical
Oncology (ASCO) and the American Society of Hematology (ASH). She was the senior executive editor of the ASH Self-Assessment Program, 8th edition and a member of the ASH guidelines panel for treating AML in older adults. She is active in the ECOG- ACRIN cooperative group and myeloMATCH program. Dr. Altman is a co-chair of the NCI leukemia steering committee. She is the vice chair of the NCCN Acute Myeloid Leukemia Panel and a member of the NCCN Chronic Myelogenous Leukemia Panel.